Suicidality
Drug research and approvals for suicidality: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 129 studies of suicidality are recruiting on ClinicalTrials.gov, and Health Canada has authorized 6 drug trials for it since 2013.
- Recruiting worldwide: 129
- Trials authorized in Canada: 6
- FDA orphan approvals: 0
- EU medicines: 0
Newest posted first, of 129 recruiting on ClinicalTrials.gov ↗
- Evaluation of a Multi-Layered Digital Phenotyping, Digital Safety Plan, and Pharmacogenomic Intervention for Suicide…NCT07885722 · Not applicable · Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · starts Sep 1, 2025
- Alleviating Suicidality by Combining Psychotherapy and IM Ketamine for Rapid Treatment in the Emergency DepartmentNCT07868913 · Phase 2 · The University of Texas Health Science Center at San Antonio · starts Sep 30, 2026
- Videoconference-Based Brief Cognitive Behavioral Therapy for Patients With Mood Disorders at High Risk for SuicideNCT07857291 · Not applicable · Hyung Keun Park · starts Nov 4, 2026
- Study to Refine the Effectiveness of New Generation Therapies for SuicideNCT07818889 · Not applicable · Ohio State University · starts Apr 29, 2026
- Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for PsychosisNCT07756567 · Not applicable · University of California, San Diego · starts Oct 1, 2026
- Disclosure, Social Harm, and Support Activation StudyNCT07730307 · Not reported · Yale University · starts May 25, 2026
- Empowerment Self Defense Program for Adult Native Women Survivors of Sexual ViolenceNCT07712796 · Not applicable · University of Michigan · starts Oct 27, 2026
- Reward Sensitivity Digital Intervention for Suicide RiskNCT07661901 · Not applicable · University of Pennsylvania · starts Aug 21, 2026
- Impact of a High-resolution Program for the Prevention of Suicidal Behavior in At-risk Adults: a Quasi-experimental…NCT07655986 · Not applicable · University of Salamanca · starts May 1, 2025
Newest first; search them all in Canada trials
| Feb 10, 2025 | Understanding and treating suicidal ideation with ketamine: a diffusion magnetic resonance imaging studyKetamine | University of Ottawa Institute of Mental Health Research | Ongoing |
| Feb 29, 2024 | Rapid reversal of suicidal depression: comparative effectiveness of ect vs. ketamine over the lifespan (reakt-sd)Ketamine | Centre for Addiction and Mental Health | Ongoing |
| Aug 21, 2023 | A randomized placebo-controlled trial of adjunctive d-cycloserine and accelerated intermittent theta burst stimulation for emerging adults with suicidal…Cycloserine | Governors of The University of Calgary | Ongoing |
| Mar 14, 2023 | A phase three, double blinded, randomized, placebo controlled, parallel arm pilot trial of intravenous ketamine for emergency department treatment of suicidal…Ketamine | Childrens Hospital of Eastern Ontario Research Institute | Closed |
| Dec 3, 2021 | Integrated internet-based cognitive behavioural therapy (i-cbt) and intravenous ketamine for suicidality in treatment-resistant depression: a randomized,…Ketamine | University Health Network | Ongoing |
| Oct 29, 2021 | Ketamine infusion for rapid reduction of suicidality in pediatrics: a pilot randomized controlled trialKetamine/ Midazolam | University of British Columbia | Ongoing |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA